Tag: Regeneron Pharmaceuticals

Regeneron Pharmaceuticals, Inc. ($REGN) Secures FDA Nod for Lynozyfic™ Targeting Relapsed Multiple Myeloma

Regeneron Pharmaceuticals, Inc. (REGN) announced that the U.S. Food and Drug Administration has granted accelerated approval for Lynozyfic™ (linvoseltamab-gcpt) to treat adult patients with...

23andMe Holding Co. (MEHCQ) to Sell Major Assets Including PGS and Lemonaid Health for...

23andMe Holding Co. has signed a definitive agreement to sell nearly all of its assets to TTAM Research Institute for $305 million. The assets...